You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chiauranib

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soft Tissue Sarcoma Trial in Guangzhou (Chiauranib)

Recruiting
  • Soft Tissue Sarcoma
  • Chiauranib
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 14, 2022

Small Cell Lung Cancer Trial in Suzhou (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Chiauranib
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Suzhou University
Jul 19, 2022

Soft Tissue Sarcoma Trial in Guangzhou (Chiauranib)

Recruiting
  • Soft Tissue Sarcoma
  • Chiauranib
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 10, 2022

Healthy Volunteers Trial in Suzhou (Chiauranib)

Active, not recruiting
  • Healthy Volunteers
  • Chiauranib
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Suzhou University
Jul 20, 2022

Small-cell Lung Cancer Trial in Canton (Chiauranib)

Recruiting
  • Small-cell Lung Cancer
  • Chiauranib
  • Canton, Ohio
    Gabrail Cancer Center Research
Jul 27, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

Recruiting
  • Small Cell Lung Cancer
  • Chiauranib
  • Placebo
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022

Ovarian Cancer, Relapsed or Refractory, Chiauranib Trial in Shanghai (chiauranib, Placebo, Paclitaxel)

Recruiting
  • Ovarian Cancer
  • +3 more
  • chiauranib
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 7, 2022

Non-hodgkin's Lymphoma Trial in Beijing (Chiauranib, Chidamide)

Completed
  • Non-hodgkin's Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 7, 2022

Small Cell Lung Cancer Trial in Beijing (Chiauranib)

Recruiting
  • Small Cell Lung Cancer
  • Chiauranib
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 8, 2022

Triple-negative Breast Cancer Trial in China (Chiauranib, capecitabine)

Recruiting
  • Triple-negative Breast Cancer
  • Guangzhou, Guangdong, China
  • +3 more
Apr 14, 2022

Hepatocellular Carcinoma Trial in Shanghai (Chiauranib)

Completed
  • Hepatocellular Carcinoma
  • Chiauranib
  • Shanghai, Shanghai, China
    Zhongshan Hospital of Fudan University
Jun 15, 2021

Ovarian Cancer Trial in Shanghai (chiauranib, etoposide, paclitaxel)

Completed
  • Ovarian Cancer
  • chiauranib
  • +2 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 17, 2021

Ovarian Cancer Trial in Shanghai (Chiauranib)

Completed
  • Ovarian Cancer
  • Chiauranib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 14, 2020

Non-Hodgkin's Lymphoma Trial in Beijing (Chiauranib)

Terminated
  • Non-Hodgkin's Lymphoma
  • Chiauranib
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jul 22, 2019

Solid Tumors Trial in Beijing (Chiauranib)

Completed
  • Solid Tumors
  • Chiauranib
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Jun 16, 2016